https://www.medicines.ie/medicines/avtozma-162-mg-solution-for-injection-in-pre-filled-pen-and-pre-filled-syringe-36745/spc
Avtozma 162 mg solution for injection in pre-filled pen and pre-filled syringe | SPC | medicines.ie
Summary of Product Characteristics for Healthcare Professionals | Celltrion Healthcare Ireland Ltd.
solution foravtozmamginjectionpre
https://vir.com.vn/celltrion-launches-avtozma-subcutaneous-formulation-in-us-148639.html
Celltrion launches AVTOZMA subcutaneous formulation in US
Mar 17, 2026 - The South Korean biopharmaceutical company began commercial distribution of its tocilizumab biosimilar self-injection product in the American market.
launchesavtozmasubcutaneousformulation